The present invention relates to a method for manufacturing a stent, the method using a jig in which detachable protruding pins are installed at all respective location points at which circumference division lines and length division lines intersect each other, the method forming cells through intersection of wire by setting any one of the location points as a start point and repeatedly bending and moving the wire from the start point upward and downward to pass over the protruding pins located in diagonal directions, wherein a first stent woven such that intersection portions formed through the intersection of a wire are spaced apart from each other in a diagonal direction and arranged one for each length division line and a second stent woven to maintain the structural stability of the first stent and to prevent the first stent from being twisted can be provided as a single stent.

The present invention is directed toward an intragastric device used to treat obesity that includes a wire mesh structure capable of changing from a compressed pre-deployment shape to an expanded post-deployment shape with a greatly increased volume. The post-deployment shape contains a light weight at the top and a heavier weight at the bottom to ensure proper positioning within the stomach. In the post-deployment shape, the device contains larger spaces in the upper portion and smaller spaces in the lower portion to sequester food and delay gastric emptying. Alternatively, the device can be enveloped by a membrane containing larger holes at the top and smaller holes at the bottom to sequester food and delay gastric emptying. The device has a dynamic weight where the weight of the device in the pre-feeding stage is less than the weight of the device in feeding or post-feeding stage.

Bioabsorbable polymeric stent patterns with linking struts between rings that are designed to fail upon deployment of the stent are disclosed.

Devices that can be delivered into a vascular system to divert flow are disclosed herein. According to some embodiments, devices are provided for treating aneurysms b diverting flow. An expandable device can comprise, for example, a plurality of strut regions and a plurality of bridge regions. Each of the strut regions may extend circumferentially about the expandable device and include a plurality of struts. Each of the plurality of bridge regions may be attached to and extend between two of the strut regions and comprise a plurality first bridges and second bridges that intersect one another and are movable relative to one another at their intersections.

A prosthetic heart valve for replacing a native atrioventricular valve includes a collapsible and expandable frame having atrial and ventricular portions each including a circumferential row of cells, and a center portion extending between the atrial and ventricular portion. The atrial portion and the ventricular portion may flare radially outwardly from the center portion in an expanded condition of the frame. A plurality of prosthetic leaflets may be mounted to the frame. At least some of the struts forming the cells in the atrial portion include an undulating structure positioned between two axially extending strut portions, the undulating structure including at least one circumferentially extending strut portion and being configured to dampen forces transmitted across the undulating structure between the two axially extending strut portions

A continuous wire stent includes a wire bent into a waveform and spirally wrapped into a helix having a plurality of bands that form a hollow cylindrical shape. The waveform includes a plurality of waves, each wave including a first outer crown including a first intrados, a second outer crown including a second intrados facing the first intrados, a first mid-crown disposed between the first outer crown and the second outer crown, a second mid-crown disposed between the second outer crown and an outer crown of a next wave of the waveform, a first strut connecting the first outer crown to the first mid-crown, a second strut connecting the first mid-crown to the second outer crown, a third strut connecting the second outer crown to the second mid-crown, and a fourth strut connecting the second mid-crown to the outer crown in the next wave of the waveform.

An implantable medical device that is fabricated from materials that present a blood or body fluid or tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of a monolithic material formed into differentiated regions defining structural members and web regions extending across interstitial spaces between the structural members. The endoluminal stent-graft is characterized by having controlled heterogeneities at the blood flow surface of the stent.

Certain embodiments of the present disclosure provide a prosthetic valve (e.g., prosthetic heart valve) and a valve delivery apparatus for delivery of the prosthetic valve to a native valve site via the human vasculature. The prosthetic valve comprises a frame or stent that comprises multiple cells arranged in unique ways. The prosthetic valve also comprises a leaflet assembly coupled to the frame and having a plurality of leaflets, wherein the leaflets are configured to allow blood to flow through the prosthetic heart valve in one direction from an inflow end portion to an outflow end portion of the frame or stent.

Devices that can be delivered into a vascular system to divert flow are disclosed herein. According to some embodiments, devices are provided for treating aneurysms b diverting flow. An expandable device can comprise, for example, a plurality of strut regions and a plurality of bridge regions. Each of the strut regions may extend circumferentially about the expandable device and include a plurality of struts. Each of the plurality of bridge regions may be attached to and extend between two of the strut regions and comprise a plurality first bridges and second bridges that intersect one another and are movable relative to one another at their intersections.

The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by open cells and at least two end portions, defined by closed cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.